Woburn, MA, United States of America

Dhan Sidhartha Chand

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Woburn, MA (US) (2021 - 2023)
  • Lexington, MA (US) (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Dhan Sidhartha Chand in Antibody Development

Introduction

Dhan Sidhartha Chand is an inventive mind located in Woburn, MA, United States. He has made significant contributions to the field of biotechnology, with a notable portfolio of five patents that showcase his dedication to advancing medical science through innovative solutions.

Latest Patents

Chand's latest patents revolve around the development of multispecific antibodies targeting immune checkpoint receptors. These include the innovative Anti-TIGIT and anti-CD96 antibodies, which are designed to bind specifically to human CD96 and TIGIT. The disclosures detail the creation of pharmaceutical compositions that incorporate these multispecific molecules and antibodies, along with nucleic acids, expression vectors, and host cells to facilitate their production. Furthermore, these inventions outline methods for treating subjects using these advanced therapies, which hold the potential to enhance cancer treatment by modulating immune responses.

Chand has also developed antibodies that specifically bind to human CD96, serving to antagonize CD96 functions. This innovation includes comprehensive pharmaceutical compositions, nucleic acids for encoding the antibodies, and methodologies for treating individuals using these targeted therapies.

Career Highlights

Dhan Sidhartha Chand is actively engaged with Agenus Inc., a company known for its pioneering work in immuno-oncology. His role in developing cutting-edge antibody therapies highlights his status as a leading inventor in the biotech sector. Chand's work reflects a commitment to creating advanced medical solutions that could play a crucial role in therapeutic applications.

Collaborations

Throughout his career, Chand has collaborated with talented professionals in the field, including Benjamin Maxime Morin and Olga Ignatovich. These partnerships exemplify the collaborative spirit prevalent in research and development, leading to innovative breakthroughs and advancements in biotechnology.

Conclusion

Dhan Sidhartha Chand's contributions to biotechnology, particularly in the realm of antibody development, underscore his innovative approach to addressing complex medical challenges. His patents not only reflect his expertise but also his potential to impact the future of immunotherapy, making him a noteworthy inventor in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…